LINC01268 promotes epithelial-mesenchymal transition, invasion and metastasis of gastric cancer via the PI3K/Akt signaling pathway and targeting MARCKS

Table 1 Association between the expression level of LINC01268 and clinicopathological factors of human gastric cancer

Characteristics	No. of each group	LINC01268 expression		P value
		High	Low
All cases	62	39	23
Age (yr)
≥ 60	38	23	15	0.626
< 60	24	16	8
Gender
Male	53	32	21	0.531
Female	9	7	2
Smoking
Yes	23	15	8	0.772
No	39	24	15
Drinking alcohol
Yes	21	14	7	0.661
No	41	25	16
Maximum tumor diameter
≥ 5	25	19	6	0.079
< 5	37	20	17
Depth of invasion
pT1-pT2	8	5	3	1.000
pT3-pT4	54	34	20
Lymph node metastasis
pN0	10	2	8	0.007
pN1-pN3	52	37	15
Distant metastasis
pM0	59	36	23	0.453
pM1	3	3	0
Tumor TNM stage
I-II	12	4	8	0.043
III-IV	50	35	15
Histology
Middle differentiated and well differentiated	23	10	13	0.015
Poor differentiated	39	29	10
Macroscopic types
Mass	3	0	3	0.378
Ulcerative	12	8	4
Infiltrative ulcerative	47	31	16
Diffuse infiltrative	0	0	0
Venous/lymphatic invasion
Positive	10	7	3	0.881
Negative	52	32	20
Nervous invasion
Positive	7	5	2	0.936
Negative	55	34	21
Fatty nodules
Positive	8	7	1	0.250
Negative	54	32	22
Liver metastasis
Present	3	2	1	1.000
Absent	59	37	22
Ascitic fluid
Negative	48	30	18	0.903
Positive	14	9	5